CRDF vs CRL · rev $145.0K vs rev $4.02B
Cardiff Oncology Inc (CRDF) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Cardiff Oncology Inc (CRDF) is a biotechnology company listed on US.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported CRDF revenue for 2026-06-30 was $145.0K. Net income was -$21.6M. CRDF currently screens at market cap $238.8M.
Latest reported CRL revenue for 2025-12-27 was $4.02B. Net income was -$144.3M. CRL currently screens at market cap $7.78B.
CRDF currently screens at market cap $238.8M. CRL currently screens at market cap $7.78B.
Not investment advice. Open the CRDF and CRL stock pages for the full models.
Not investment advice.